SANAI HEALTH GP released its interim results, with a loss attributable to shareholders of 10.861 million yuan, turning f…
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, SANAI HEALTH GP released its interim results for the six months ending June 30, 2025, reporting revenue of 47.222 million yuan, an increase of 28.57% year-on-year; the loss attributable to shareholders was 10.861 million yuan, compared to a profit of 9.971 million yuan in the same period last year; the loss per share was 0.071 yuan. The announcement stated that the increase in revenue was mainly due to the increase in revenue from the sale of pharmaceutical products by Beijing Hangyang during this period
According to the Zhitong Finance APP, SANAI HEALTH GP (01889) announced its interim results for the six months ending June 30, 2025. The group achieved revenue of HKD 47.222 million, an increase of 28.57% year-on-year; the loss attributable to shareholders was HKD 10.861 million, compared to a profit of HKD 9.971 million in the same period last year; the loss per share was 7.1 cents.
The announcement stated that the increase in revenue was mainly due to the increase in revenue from the sales of pharmaceutical products by Beijing Hangyang during this period